Page last updated: 2024-09-05

lasofoxifene and tibolone

lasofoxifene has been researched along with tibolone in 2 studies

Compound Research Comparison

Studies (lasofoxifene)	Trials (lasofoxifene)	Recent Studies (post-2010) (lasofoxifene)	Studies (tibolone)	Trials (tibolone)	Recent Studies (post-2010) (tibolone)
88	14	24	927	336	162

Protein Interaction Comparison

Protein	Taxonomy	tibolone (IC50)
Estrogen receptor	Homo sapiens (human)	0.4333
Androgen receptor	Rattus norvegicus (Norway rat)	0.113
Sodium-dependent serotonin transporter	Homo sapiens (human)	0.0907
Cytochrome P450 2C19	Homo sapiens (human)	3

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arun, B; Brown, PH; Castiglione, M; Cuzick, J; DeCensi, A; Dunn, B; Forbes, JF; Glaus, A; Howell, A; Vogel, V; von Minckwitz, G; Zwierzina, H	1
Briarava, M; Mocellin, S; Nitti, D; Pilati, P	1

Reviews

2 review(s) available for lasofoxifene and tibolone

Article	Year
Preventive therapy for breast cancer: a consensus statement. The Lancet. Oncology, 2011, Volume: 12, Issue:5 Topics: Anastrozole; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Consensus Development Conferences as Topic; Diphosphonates; Estrogen Receptor Modulators; Expert Testimony; Female; Fenretinide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Nitriles; Norpregnenes; Piperidines; Premenopause; Pyrrolidines; Raloxifene Hydrochloride; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Triazoles	2011
Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. Journal of the National Cancer Institute, 2016, Volume: 108, Issue:2 Topics: Adult; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Norpregnenes; Piperidines; Postmenopause; Primary Prevention; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes	2016

Article

Year

Preventive therapy for breast cancer: a consensus statement.

The Lancet. Oncology, 2011, Volume: 12, Issue:5

Topics: Anastrozole; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Consensus Development Conferences as Topic; Diphosphonates; Estrogen Receptor Modulators; Expert Testimony; Female; Fenretinide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Nitriles; Norpregnenes; Piperidines; Premenopause; Pyrrolidines; Raloxifene Hydrochloride; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Triazoles

2011

Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials.

Journal of the National Cancer Institute, 2016, Volume: 108, Issue:2

Topics: Adult; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Norpregnenes; Piperidines; Postmenopause; Primary Prevention; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes

2016